A randomized, placebo-controlled clinical trial evaluating olipudase alfa enzyme replacement therapy for chronic acid sphingomyelinase deficiency (ASMD) in adults: One-year resultsMelissa Wasserstein, Monica Kumar, Roberto Giugliani et al.|Genetics in Medicine|2022Cited by 99
Recessive mutations in ATP8A2 cause severe hypotonia, cognitive impairment, hyperkinetic movement disorders and progressive optic atrophyHugh J. McMillan, Grace Yoon, Aida Telegrafi et al.|Orphanet Journal of Rare Diseases|2018Cited by 45
Recurrent Biallelic p.<scp>L347P <i>PINK1</i></scp> Variant in Polynesians with Parkinsonism and Isolated Dopa‐Responsive DystoniaHugo Morales‐Briceño, Victor S.C. Fung, Tien Lee Ong et al.|Movement Disorders Clinical Practice|2022Cited by 7